FcγRIIIA and FcγRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin’s lymphoma patients treated with sequential CHOP and rituximab

We analyzed FcγRIIIA-158V/F and FcγRIIA-131H/R polymorphisms in a cohort of 94 newly diagnosed follicular lymphoma (FL) patients sequentially treated with CHOP and Rituximab. With a median follow-up of 5.8 years, the overall survival at 8 years is 83%. Univariate and multivariate analysis showed no...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	Emanuela Carlotti, Giuseppe A. Palumbo, Elena Oldani, Daniele Tibullo, Silvia Salmoiraghi, Andrea Rossi, Josee Golay, Alessandro Pulsoni, Robin Foà, Alessandro Rambaldi
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2007-08-01
Online Access:	https://haematologica.org/article/view/4544